-
.
.
why novartis� landmark cancer drug approval is great news for bluebird
.
.
.�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�
http://lm360.us/Hocking-father-of-Bandanza-from-Vitria-Da-Conquista?Dureposis=189
.
"we were quite surprised to find there were no significant differences," says study author
.
?????
�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.� http://lm360.us/Hocking-father-of-Bandanza-from-Vitria-Da-Conquista?Dureposis=189 .
"we were quite surprised to find there were no significant differences," says study author .